Showing results (91-100 of 345) with videos related to
Sort By:
Pageof 35
JOP : Journal of the Pancreas|September 26, 2006
Pro-inflammatory cytokines affect pancreatic carcinoma cell. Endothelial cell interactionsMiranda ten Kate, Leo J Hofland, Peter M van Koetsveld, et al.The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Somatostatin modulates G-CSF-induced but not interleukin-3-induced proliferative responses in myeloid 32D cells via activation of somatostatin receptor subtype 2S P Oomen, A C Ward, L J Hofland, et al.Bioconjugate Chemistry|November 21, 2002
Selective alkylation and acylation of alpha and epsilon amino groups with PEG in a somatostatin analogue: tailored chemistry for optimized bioconjugatesMargherita Morpurgo, Cristina Monfardini, Leo J Hofland, et al.Clinical Endocrinology|August 1, 1993
A case of antibody formation against octreotide visualized with 111In-octreotide scintigraphyD J Kwekkeboom, J Assies, L J Hofland, et al.Anaesthesia|April 12, 2003
Comparison of closed circuit and Fick-derived oxygen consumption in patients undergoing simultaneous aortocaval occlusionJ Hofland, R Tenbrinck, C H J van Eijck, et al.Endocrinology|August 1, 1992
Dissociation of antiproliferative and antihormonal effects of the somatostatin analog octreotide on 7315b pituitary tumor cellsL J Hofland, P M van Koetsveld, N Wouters, et al.American Journal of Cancer Research|August 14, 2015
IFN-β is a potent inhibitor of insulin and insulin like growth factor stimulated proliferation and migration in human pancreatic cancer cellsStephanie Booy, Casper Hj van Eijck, Joseph Amjl Janssen, et al.Drugs of Today (Barcelona, Spain : 1998)|March 7, 2013
Pasireotide, a multi-somatostatin receptor ligand with potential efficacy for treatment of pituitary and neuroendocrine tumorsR A Feelders, W W de Herder, S J Neggers, et al.Clinical Endocrinology|November 9, 2012
Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatmentR van der Pas, F W G Leebeek, L J Hofland, et al.Digestion|January 1, 1996
Somatostatin receptor manipulationH A Visser-Wisselaar, L J Hofland, C J van Uffelen, et al.Pageof 35